DBV Technologies S.A.

Contributing Author

Recent Articles by DBV Technologies S.A.

Feb-05	Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026 DBVT -8.33% GlobeNewswire
Jan-16	DBV Technologies Announces 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing DBVT +10.53% GlobeNewswire
Jan-12	Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 DBVT +5.41% DBVT -5.02% GlobeNewswire
Jan-07	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBVT +8.18% DBVT -5.50% GlobeNewswire
Jan-05	Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 DBVT -10.81% GlobeNewswire
Dec-16	DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Years DBVT +25.42% DBVT GlobeNewswire
Dec-02	Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025 DBVT GlobeNewswire
Nov-11	DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Years DBVT GlobeNewswire
Nov-04	DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference DBVT GlobeNewswire
Nov-03	DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer DBVT GlobeNewswire
Nov-03	Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025 DBVT GlobeNewswire
Oct-30	DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBVT -7.36% GlobeNewswire
Oct-30	DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting DBVT -7.36% GlobeNewswire
Oct-29	DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBVT GlobeNewswire
Oct-28	DBV Technologies Reports Third Quarter 2025 Financial Results DBVT GlobeNewswire
Oct-06	DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBVT +7.15% DBVT GlobeNewswire
Sep-18	DBV Technologies Announces Resignation of Board Member DBVT GlobeNewswire
Sep-05	DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBVT GlobeNewswire
Sep-03	DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference DBVT GlobeNewswire
Aug-01	Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 DBVT +5.76% GlobeNewswire
Jul-29	DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBVT GlobeNewswire
Jul-29	DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBVT GlobeNewswire
Jul-28	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBVT GlobeNewswire
Jul-22	DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBVT GlobeNewswire
Jun-25	DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 - 3 Years Old DBVT +6.60% DBVT GlobeNewswire
Jun-12	DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBVT +11.12% DBVT -6.09% GlobeNewswire
Jun-11	DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting DBVT GlobeNewswire
Jun-04	Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025 DBVT +5.04% DBVT GlobeNewswire
Jun-03	DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBVT GlobeNewswire
May-15	Combined General Meeting of June 11, 2025 DBVT GlobeNewswire
May-06	Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025 DBVT GlobeNewswire
May-05	DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBVT GlobeNewswire

DBV Technologies S.A.

Recent Articles by DBV Technologies S.A.

Upgrade your FINVIZ experience